Please assess the completion status of the following clinical trial:

Trial Title: An Study of Aripiprazole in the Treatment of Methamphetamine Dependence

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Patients,Diagnostic and Statistical Manual of Mental Disorders 4thed. (DSM-IV) criteria for Methamphetamine dependence.~2. Must sign a Information consent form.~3. Required to provide detailed address and phone number~Exclusion Criteria:~1. Serious organic disease.~2. Suicide ideation or hurt others.~3. Taking antipsychotic within two weeks before.~4. drug allergy to Risperidone or Aripiprazole.~5. pregnancy and breastfeeding women.

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Aripiprazole (Type: EXPERIMENTAL): Aripiprazole arm,5mg/pill,10mg/day.last12weeks.
- Sugar pill (Type: PLACEBO_COMPARATOR): placebo arm,5mg/pill,10mg/day,last12weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).